<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title> Survival Analysis - Competing Risk</title>

<script src="site_libs/header-attrs-2.29/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/cerulean.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/textmate.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link href="site_libs/pagedtable-1.1/css/pagedtable.css" rel="stylesheet" />
<script src="site_libs/pagedtable-1.1/js/pagedtable.js"></script>
<link href="site_libs/font-awesome-6.5.2/css/all.min.css" rel="stylesheet" />
<link href="site_libs/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Zehui Bai</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="index.html">
    <span class="fa fa-home"></span>
     
    Home
  </a>
</li>
<li>
  <a href="02-Clinical_Experience.html">
    <span class="fa fa-user"></span>
     
    Clinical Experience
  </a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-sliders"></span>
     
    Sample Size
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="03-SSC-Everything-to-Know-About-Sample-Size-Determination.html">Everything to Know About Sample Size Determination</a>
    </li>
    <li>
      <a href="03-SSC-Choosing-the-Effect-Size-for-Sample-Size-Calculations.html">Choosing the Effect Size</a>
    </li>
    <li>
      <a href="03-SSC-Biosimilar-Trials.html">Statistical Considerations for the Design and Analysis of Biosimilar Trials</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-and-Power-for-Non-Parametric-Analysis.html">Sample Size and Power for Non-Parametric Analysis</a>
    </li>
    <li>
      <a href="03-SSC-Power-for-Complex-Hypotheses.html">Power for Complex Hypotheses</a>
    </li>
    <li>
      <a href="03-SSC-Alternatives-to-Power.html">Bayesian methods - Alternatives to Power</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-for-Pilot-Studies.html">Sample Size for Pilot Studies</a>
    </li>
    <li>
      <a href="03-SSC-Case-Continuous-Endpoint.html">Sample Size Determination for Continuous Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Case-Categorical-Endpoint.html">Sample Size Determination for Categorical Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Sample-Size-Determination-for-Counts-and-Rates.html">Sample Size Determination for Counts and Rates</a>
    </li>
    <li>
      <a href="03-SSC-Case-Survival-Endpoint.html">Sample Size Determination for Survival Endpoint</a>
    </li>
    <li>
      <a href="03-SSC-Case-Repeated-Measures.html">Sample Size Determination for Repeated Measures</a>
    </li>
    <li>
      <a href="03-SSC-IA-Sequential-Design.html">Statistical Considerations for Group Sequential Design</a>
    </li>
    <li>
      <a href="03-SSC-IA-Adaptive-Design.html">Statistical Considerations for Adaptive Design</a>
    </li>
    <li>
      <a href="03-SSC-Multiple-Test.html">Sample Size for Multiple Test</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-pencil-square-o"></span>
     
    Study Design
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="04-Design-Estimands-Framework.html">Estimands Framework</a>
    </li>
    <li>
      <a href="04-Design-Estimands-Practice.html">Estimands and Sensitivity Analyses</a>
    </li>
    <li>
      <a href="04-Design-Phase-I-Trials---Design-Considerations.html">Phase I Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-II-Trials---Design-Considerations.html">Phase II Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-III-Trials---Design-Considerations.html">Phase III Trials - Design Considerations</a>
    </li>
    <li>
      <a href="04-Design-Phase-IV-Trials---Design-Considerations.html">Phase IV Trials - Design Considerations for Post Marketing Surveillance</a>
    </li>
    <li>
      <a href="04-Design-Complex-Sequential-Trials.html">Complex Sequential Analysis Trials</a>
    </li>
    <li>
      <a href="04-Design-Adaptive-Clinical-Trials.html">Adaptive Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Bayesian-Clinical-Trials.html">Bayesian Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Dose-Escalation-and-Stratification-Designs.html">Dose Escalation and Stratification Designs in Early Oncology Development</a>
    </li>
    <li>
      <a href="04-Design-Single-Arm-Clinical-Trials.html">Single Arm Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Diagnostic-Study-Design-and-Evaluation.html">Diagnostic Study-Design and Evaluation</a>
    </li>
    <li>
      <a href="04-Design-Diagnostic-Study-MRMC.html">Diagnostic Study-Multireader Multicase (MRMC)</a>
    </li>
    <li>
      <a href="04-Design-Hierarchical-composite-endpoints.html">Hierarchical Composite Endpoints</a>
    </li>
    <li>
      <a href="04-Design-Externally-Controlled-Trials.html">Considerations for the Design and Conduct of Externally Controlled Trials</a>
    </li>
    <li>
      <a href="04-Design-Noninferiority-Trials.html">Noninferiority Trials</a>
    </li>
    <li>
      <a href="04-Design-Bioequivalence-and-Biosimilar-Trials.html">Bioequivalence and Biosimilar Trials</a>
    </li>
    <li>
      <a href="04-Design-Exploring-Survival-Analysis-Designs-for-Clinical-Trials.html">Exploring Survival Analysis Designs for Clinical Trials</a>
    </li>
    <li>
      <a href="04-Design-Projecting-How-Long-Your-Trial-Will-Take.html">Projecting How Long Your Trial Will Take</a>
    </li>
    <li>
      <a href="04-Design-Regulatory-Submission.html">Regulatory Submission from Stats Perspective</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-line-chart"></span>
     
    Data Visualization
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="05-Plot-Adverse-Event.html">Adverse Event Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Laboratory-Data.html">Laboratory Data Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Time-To-Event.html">Time to Event Data Visualization</a>
    </li>
    <li>
      <a href="05-Plot-PRO-Data.html">Patient Reported Outcome Data Visualization</a>
    </li>
    <li>
      <a href="05-Plot-SSC-and-Power-Calculation.html">Sample Size and Power Calculations Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Correlation.html">Correlation Visualization</a>
    </li>
    <li>
      <a href="05-Plot-Model-Table.html">Clinical Data and Model visualization</a>
    </li>
    <li>
      <a href="05-Plot-ScatterPlot.html">Scatter and Line Plot</a>
    </li>
    <li>
      <a href="05-Plot-BarPlot.html">Bar Chart</a>
    </li>
    <li>
      <a href="05-Plot-PieChart.html">Pie Chart</a>
    </li>
    <li>
      <a href="05-Plot-BoxPlot.html">Box Plot</a>
    </li>
    <li>
      <a href="05-Plot-Histogram.html">Histogram</a>
    </li>
    <li>
      <a href="05-Plot-Forest-Plot.html">Forest Plot</a>
    </li>
    <li>
      <a href="05-Plot-Flow-Chart.html">Flow Chart</a>
    </li>
    <li>
      <a href="05-Plot-Some-Interesting.html">Some Interesting Plots</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-calculator"></span>
     
    Statistical Analysis
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="06-Analysis-Linear-Regression.html">Linear Regression</a>
    </li>
    <li>
      <a href="06-Analysis-Logistic-Regression.html">Logistic Regression</a>
    </li>
    <li>
      <a href="06-Analysis-Mixed-Model.html">Mixed Model</a>
    </li>
    <li>
      <a href="06-Analysis-MMRM.html">Mixed Model Repeated Measures</a>
    </li>
    <li>
      <a href="06-Analysis-GEE.html">Generalized Estimating Equation</a>
    </li>
    <li>
      <a href="06-Analysis-ANOVA.html">Analysis of Variance</a>
    </li>
    <li>
      <a href="06-Analysis-Survival-Analysis.html">Survival Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-Survival-Competing-Risk.html">Survival Analysis - Competing Risk</a>
    </li>
    <li>
      <a href="06-Analysis-Missing-Data.html">Missing Data Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-MI-Implementation.html">Multiple Imputation Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-SSD.html">Safety Signal Detection and Evaluation</a>
    </li>
    <li>
      <a href="06-Analysis-Meta-Analysis.html">Meta Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-PK-and-PD.html">PK and PD Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-Time-Series-Analysis.html">Time Series Analysis</a>
    </li>
    <li>
      <a href="06-Analysis-SEM.html">Structural Equation Modeling</a>
    </li>
    <li>
      <a href="06-Analysis-Factor-Analysis.html">Factor Analysis</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-bar-chart"></span>
     
    Machine Learning
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="07-ML-Bayesian-Theory.html">Bayesian Theory</a>
    </li>
    <li>
      <a href="07-ML-Bayesian-Analysis.html">Bayesian Analysis</a>
    </li>
    <li>
      <a href="07-ML-Regularization-Penalized-Regression.html">Regularization Penalized Regression</a>
    </li>
    <li>
      <a href="07-ML-Loss-Regression.html">Loss Functions in Machine Learning</a>
    </li>
    <li>
      <a href="07-ML-PCA.html">Principal Component Analysis</a>
    </li>
    <li>
      <a href="07-ML-KNN.html">K-Nearest Neighbors</a>
    </li>
    <li>
      <a href="07-ML-SVM.html">Support Vector Machine</a>
    </li>
    <li>
      <a href="07-ML-Tree-Models.html">Tree Models</a>
    </li>
    <li>
      <a href="07-ML-LDA.html">Linear Discriminant Analysis</a>
    </li>
    <li>
      <a href="07-ML-Cluster-Analysis.html">Cluster Analysis</a>
    </li>
    <li>
      <a href="07-ML-Neural-Networks.html">Neural Network</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="08-CV.html">
    <span class="fa fa-file-pdf-o"></span>
     
    CV
  </a>
</li>
<li>
  <a href="mailto:zehuibai@outlook.com">
    <span class="fa fa-envelope-o"></span>
     
    Contact me
  </a>
</li>
<li>
  <a href="https://github.com/Zehuibai">
    <span class="fa fa-github"></span>
     
    GitHub
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore"><p><img src="logo.png"
style="width:3in" /><br />
Survival Analysis - Competing Risk</p></h1>

</div>


<div id="competing-risk" class="section level1">
<h1>Competing Risk</h1>
<div id="introduction" class="section level2">
<h2>Introduction</h2>
<p>Competing risk are said to be present when a patient is at risk of
more than one mutually exclusive event, such as death from different
cause which will prevent any other from happening. Competing risk models
provide real world probabilities of death when competing events are
present as opposed to standard survival models by allowing us to
separate the probability of event into different causes.</p>
<p>Examples:</p>
<ul>
<li>recurrence</li>
<li>death from disease</li>
<li>death from other causes</li>
<li>treatment response</li>
</ul>
<p>In presence of competing events, the standard product-limit method of
estimating survivor function for the event of interest <strong>yields
biased results</strong> as the probability of occurrence is modified by
an antecedent competing event.</p>
<p>The biggest drawback of competing risks analysis is the requirement
that times for different event types be <strong>independent</strong> or
<strong>at least that each event be noninformative</strong> for the
others.</p>
<p>The fundamental problem that may lead to the need for specialized
statistical methods is unobserved dependence among the various event
times. For example, one can imagine that patients who recur are more
likely to die, and therefore times to recurrence and times to death
would not be independent events.</p>
<p>There are two approaches to analysis in the presence of multiple
potential outcomes:</p>
<ul>
<li>Cause-specific hazard of a given event: this represents the rate per
unit of time of the event among those not having failed from other
events</li>
<li>Subdistribution hazard of a given event: this represents the rate
per unit of time of the event as well as the influence of competing
events</li>
</ul>
<p>Each of these approaches may only illuminate one important aspect of
the data while possibly obscuring others, and the chosen approach should
depend on the question of interest.</p>
<p>When the events are independent (almost never true), cause-specific
hazards is unbiased. When the events are dependent, a variety of results
can be obtained depending on the setting.</p>
<p>Cumulative incidence using 1 minus the Kaplan-Meier estimate is
always &gt;= cumulative incidence using competing risks methods, so can
only lead to an overestimate of the cumulative incidence, though the
amount of overestimation depends on event rates and dependence among
events.</p>
<p>To establish that a covariate is indeed acting on the event of
interest, cause-specific hazards may be preferred for treatment or
prognostic marker effect testing. To establish overall benefit,
subdistribution hazards may be preferred for building prognostic
nomograms or considering health economic effects to get a better sense
of the influence of treatment and other covariates on an absolute
scale.</p>
</div>
<div id="type-specific-hazards" class="section level2">
<h2>Type-specific hazards</h2>
<p>As before, let <span class="math inline">\(T_{i}\)</span> be a random
variable denoting the time of death for person <span
class="math inline">\(i\)</span>. Now let <span
class="math inline">\(J_{i}\)</span> be a random variable denoting the
type of death that occurred to person <span
class="math inline">\(i\)</span>. Thus, <span
class="math inline">\(J_{5}=2\)</span> means that person 5 died of
cancer. We now define <span class="math inline">\(h_{i j}(t)\)</span>,
the hazard for death type <span class="math inline">\(j\)</span> at time
<span class="math inline">\(t\)</span> for person <span
class="math inline">\(i\)</span>, as follows:</p>
<p><span class="math display">\[h_{i j}(t)=\lim _{\Delta t \rightarrow
0} \frac{\operatorname{Pr}\left(t&lt;T_{i}&lt;t+\Delta t, J_{i}=j \mid
T_{i} \geq t\right)}{\Delta t}, \quad j=1, \ldots, 5\]</span></p>
<p>The overall hazard of death is just the sum of all the typespecific
hazards: <span class="math display">\[h_{i}(t)=\sum_{j} h_{i
j}(t)\]</span> Based on the type-specific hazards, we can also define
type-specific survival functions: <span
class="math display">\[S_{j}(t)=\exp \left\{-\int_{0}^{t} h_{j}(u) d
u\right\}\]</span></p>
<p>we can define the hypothetical variable <span
class="math inline">\(T_{i j}\)</span> as the time at which the <span
class="math inline">\(j_{t h}\)</span> event type either occurred to the
ith person or would have occurred if other event types had not preceded
it. In other words, we suppose that a person who dies of cancer at time
<span class="math inline">\(T_{2}\)</span> would have later died of
heart disease at time <span class="math inline">\(T_{1}\)</span> if the
cancer death had not occurred. For a given set of <span
class="math inline">\(T_{i j} \mathrm{~s}\)</span>, we only observe the
one that is smallest. If we further assume that the <span
class="math inline">\(T_{i j} \mathrm{~s}\)</span> are independent
across event types, we can say that <span class="math display">\[
S_{i j}(t)=\operatorname{Pr}\left(T_{i j}&gt;t\right)
\]</span> That is, the type-specific survival function gives the
probability that an event of type j occurs later than time t.</p>
<p><strong>Non-informative</strong></p>
<p>If the estimate is to be unbiased, the censor must be uninformative.
For competitive risks, we must make exactly the same assumptions. In
other words, we must assume that, on the condition of covariates, those
who are at a particularly high (or low) risk of one type of event will
not (or less) experience other types of events. Therefore, if we know
that someone died of heart disease at the age of 50, that would not give
us any information (except the information we derive from the
covariates), and there is no information about his risk of dying from
cancer at that age.</p>
</div>
<div id="covariate-effects-via-cox-model" class="section level2">
<h2>Covariate effects via COX model</h2>
<ul>
<li>The first model treats all event types the same.</li>
<li>The second model focuses on type 3 by treating types 1 and 2 as
censoring.</li>
<li>That’s followed by a model for type 2, treating types 1 and 3 as
censoring</li>
</ul>
<p>These tests are only valid when using the Breslow method for handling
ties or when there are no tied event times. With tied event times:
TIES=EFRON</p>
<pre><code>PROC PHREG DATA=leaders;
 MODEL years*lost(0)=manner start military age conflict
 loginc growth pop land literacy;
 STRATA region;
 
PROC PHREG DATA=leaders;
 MODEL years*lost(0,1,2)=manner start military age conflict
 loginc growth pop land literacy;
 STRATA region;
 
PROC PHREG DATA=leaders;
 MODEL years*lost(0,1,3)=manner start military age conflict
 loginc growth pop land literacy;
 STRATA region;
RUN;</code></pre>
</div>
</div>
<div id="competing-risk-analysis-in-sas" class="section level1">
<h1>Competing Risk Analysis in SAS</h1>
<div id="cumulative-incidence-function-cif" class="section level2">
<h2>Cumulative incidence function (CIF)</h2>
<div id="introduction-1" class="section level3">
<h3>Introduction</h3>
<p>Based on type-specific survival functions: <span
class="math display">\[S_{j}(t)=\exp \left\{-\int_{0}^{t} h_{j}(u) d
u\right\}\]</span></p>
<p>It can be interpreted as the probability that a person arrives at
time <span class="math inline">\(t\)</span> without an event of type
<span class="math inline">\(j\)</span> under the assumption that no
other type of event may occur. <span
class="math display">\[F_{j}(t)=1-S_{j}(t)\]</span> This is not
considered a useful feature. Because the sum of the probabilities of
various events that occurred before time t may usually exceed 1. <span
class="math display">\[\sum_{j} F_{j}(t) \ge 1\]</span> Instead, many
people prefer to estimate the cumulative incidence function, This
equation estimates the probability that an event of type j happens to
individual i before time t, in the presence of competing event types.
which is defined as <span
class="math display">\[I_{j}(t)=\operatorname{Pr}\left(T_{i}&lt;t,
J_{i}=j\right)\]</span> The consistent estimate of the cumulative
incidence function is given by <span
class="math display">\[\hat{I}_{j}(t)=\sum_{k \mid t_{k} \leq t}
\hat{S}\left(t_{k}\right) \frac{d_{j k}}{n_{k}}\]</span></p>
<ul>
<li>where <span class="math inline">\(\hat{S}(t)\)</span> is the
Kaplan-Meier estimate of the overall survivor function,</li>
<li><span class="math inline">\(d_{j k}\)</span> is the number of events
of type <span class="math inline">\(j\)</span> that occurred at time
<span class="math inline">\(t_{k}\)</span>,</li>
<li><span class="math inline">\(n_{k}\)</span> is the number at risk at
time <span class="math inline">\(t_{k}\)</span>.</li>
<li>The ratio of <span class="math inline">\(d_{j k}\)</span> to <span
class="math inline">\(n_{k}\)</span> is an estimate of the hazard of
event type <span class="math inline">\(j\)</span> at time <span
class="math inline">\(t_{k}\)</span></li>
</ul>
<p>An attractive feature of this estimator is <span
class="math display">\[
\hat{S}(t)+\sum_{j} \hat{I}_{j}(t)=1
\]</span></p>
<p>This says that at any time t, the probabilities for all the event
types plus the probability of no event add up to 1. Another attraction
is that the method does not depend on the assumption that each event
type is noninformative for other event types.</p>
</div>
<div id="proc-lifetest" class="section level3">
<h3>Proc Lifetest</h3>
<p>For competitive risk data, PROC LIFETEST estimates the cumulative
incidence function (CIF). If you have multiple data samples, it will
estimate the CIF for each sample and compare the CIF between the samples
by using the Gray test (Gray 1988). The estimated CIF is a step
function, with a jump at each different time when the event of interest
occurs. If there are a large number of such events, the estimated CIF
table may be very long. If you are interested in the cumulative
incidence of specific time points, you can use the TIMELIST = option in
the PROC LIFETEST statement to specify these time points, and PROC
LIFETEST only prints the estimated CIF values at these time points.</p>
<p><a
href="https://documentation.sas.com/doc/en/pgmsascdc/9.4_3.3/statug/statug_lifetest_examples04.htm">source</a></p>
<ul>
<li>Censoring <span class="math inline">\(c_{i}=0\)</span></li>
<li>Without censoring (had a event) <span
class="math inline">\(c_{i}=1\)</span></li>
<li>Competing events <span class="math inline">\(c_{i}=2\)</span></li>
</ul>
<!-- -->
<pre><code>proc format;
    value RG 1=&#39;MelaGenix® Low Risk&#39; 0=&#39;MelaGenix® High Risk&#39;;
run;
*** IF censoring then Status = 0;
*** IF Melanoma-specific death then Status = 1;
*** IF other death then Status = 2;
data MSS_Dummy;
    input Days Status Group Site $ @@;
    format Group RG.;
    datalines;
   1179 1 1 A 
    378 0 1 B
    956 1 1 C 
    355 1 1 A
   1432 0 1 B
    262 1 1 B 
    819 2 1 C
    256 1 1 A 
   2256 2 1 B
    255 1 1 C 
   1171 1 1 A
    224 0 1 B 
   1325 1 1 C
    225 1 0 A 
   1325 2 1 B
   1256 1 1 A 
    256 2 0 B
    255 0 1 C 
   1171 2 1 A
    224 0 1 B 
    325 1 0 C
   1225 0 1 A 
    725 1 1 B
    287 2 1 C 
    217 0 0 A
    319 1 1 B 
   1255 2 1 A
    264 0 1 C 
    256 1 1 B
    237 0 0 C 
    291 1 1 A
   1156 0 0 B 
    323 0 0 C
    270 1 0 A 
    253 1 1 B
   1257 2 0 C 
    206 1 0 A
    242 0 1 B 
   1206 1 0 A
    157 1 0 C 
    237 1 1 B
   1249 0 0 B 
    211 1 0 C
    180 0 0 B 
    229 1 1 C
    226 1 0 A 
   1234 2 1 A
    268 0 0 B 
    209 1 0 C
;


*** Log Rank Test;
ods graphics on;
ods trace on;
ods output  CensoredSummary =_censorsum
            HomTests = _Hom; 
proc lifetest data=MSS_Dummy NOTABLE 
              outsurv = MSS_Dummy_Output 
              alpha = 0.0074 
              plots=(survival(atrisk)); 
    time Days*Status(0);
    strata Group / group = site;
run;
ods output close;
ods trace off; 
ods graphics off;


*** Cumulative incidence function (CIF);
ods graphics on;
proc lifetest data=MSS_Dummy 
              alpha = 0.0222
              plots=CIF(test) 
              timelist=0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0;
   time Days*Status(0)/eventcode=1;
   strata Group / order=internal;
run;
ods graphics off;</code></pre>
<p><strong>Stratified Gray’s Test</strong></p>
<p>Specify the GROUP= option in the STRATA statement, PROC LIFETEST
enables you to perform a stratified test to evaluate the homogeneity of
the CIFs between groups.</p>
<pre><code>ods graphics on;
proc lifetest data=MSS_Dummy 
              alpha = 0.0222
              plots=CIF(test) 
              timelist=0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0;
   time Days*Status(0)/eventcode=1;
   strata site  /group=Group order=internal;
run;
ods graphics off;</code></pre>
</div>
</div>
<div id="subdistribution-hazard-function" class="section level2">
<h2>Subdistribution hazard function</h2>
<div id="introduction-2" class="section level3">
<h3>Introduction</h3>
<p>Hazard function, <span class="math inline">\(h(t)]\)</span> The
instantaneous strength of the probability that the observed individual
surviving at this moment dies at <span class="math inline">\(t\)</span>,
the formula is <span class="math display">\[
h(t)=\lim _{\Delta t \rightarrow 0} \frac{P(t \leqslant T&lt;t+\Delta t
\mid T \geqslant t)}{\Delta t}
\]</span> If there is no competitive risk, the Cox proportional hazard
model is <span class="math display">\[
\log [\lambda(t)]=\log \left[\lambda_{0}(t)\right]+X \beta
\]</span> Among them, <span class="math inline">\(\lambda(t)\)</span> is
the net risk rate, and <span
class="math inline">\(\lambda_{0}(t)\)</span> is the baseline risk
function, that is, the risk function when the covariate vector is 0,
which can be written as <span
class="math display">\[\lambda(t)=\lambda_{0}(t) \exp (\mathrm{X}
\beta)\]</span></p>
<p>If there is a risk of competition, the <strong>condition of
“censoring independence”</strong> is not met at this time, and there are
two models:</p>
<ul>
<li><p>Subdistribution hazard function (CIF regression model, Fine-Gray
model)</p>
<ul>
<li>Represents the instantaneous probability intensity of the occurrence
of the <span class="math inline">\(k\)</span> event of the observed
individual without the <span class="math inline">\(k\)</span> event at
the time <span class="math inline">\(t\)</span></li>
</ul></li>
<li><p>Cause-specific hazard</p>
<ul>
<li>Represents the instantaneous probability intensity of the occurrence
of the <span class="math inline">\(k\)</span> event of the observed
individual without any event at the time <span
class="math inline">\(t\)</span></li>
</ul></li>
</ul>
</div>
<div id="modeling-using-proc-phreg" class="section level3">
<h3>Modeling using proc phreg</h3>
<p><span class="math display">\[\lambda_{K}^{S D}(t)=\lim _{\Delta t
\rightarrow 0} \frac{P[t \leqslant T&lt;t+\Delta t, D=k \mid T&gt;t
\cup(T&lt;t \cap K \neq k)]}{\Delta t}\]</span></p>
<pre><code>*** Mainly concerned about the outcome A corrected CIF, SD model;
proc phreg data＝cohort plots(overlay＝stratum)＝cif；
    model time*y(0)＝cov1~covn /eventcode ＝ 1 rl；
run；

*** Competitive risk event B corrected CIF, SD model;
proc phreg data＝cohort plots(overlay＝stratum)＝cif； 
    model time*y(0)＝cov1~covn /eventcode＝2 rl；
run；</code></pre>
</div>
</div>
<div id="cause-specific-hazard-function" class="section level2">
<h2>Cause-specific hazard function</h2>
<div id="modeling-using-proc-phreg-1" class="section level3">
<h3>Modeling using proc phreg</h3>
<p>CS represents the instantaneous probability intensity of the
occurrence of the <span class="math inline">\(k\)</span> event of the
observed individual without any event at the time <span
class="math inline">\(t\)</span>. In words, It is a conditional
probability that a subject with covariates <span
class="math inline">\(x\)</span> dies in the interval <span
class="math inline">\([t, t+d t]\)</span> and the event of interest is
jth cause, given that the subject was alive just before time t.</p>
<p><span class="math display">\[\lambda_{K}^{C s}(t)=\lim _{\Delta i
\rightarrow 0} \frac{P(t \leqslant T&lt;t+\Delta t, D=k \mid T \geqslant
t)}{\Delta t}\]</span></p>
<p>The principal estimable quantity in competing risks is the
causespecific hazard function <span
class="math inline">\(\lambda_{\mathrm{k}}(\mathrm{t})\)</span>, which
can heuristically be thought of as a probability of failure specifically
resulting from cause <span class="math inline">\(\mathrm{k}\)</span> in
a small interval of time, given that no failure of any kind has occurred
thus far. The overall hazard <span
class="math inline">\(\lambda(\mathrm{t})\)</span> for any type of
failure at time <span class="math inline">\(\mathrm{t}\)</span> is the
sum of the cause-specific hazards <span
class="math inline">\(\lambda_{\mathrm{k}}(\mathrm{t})\)</span>. The
cumulative causespecific hazard function <span
class="math inline">\(\Lambda{\mathrm{k}}(\mathrm{t})\)</span> or
cumulative hazard function <span
class="math inline">\(\Lambda(\mathrm{t})\)</span> equals the value of
its corresponding hazard function summed up to time <span
class="math inline">\(t\)</span>. Note that the cumulative hazard
function is uniquely related to the familiar survival function
(probability of survival past time <span
class="math inline">\(t\)</span> ) via <span
class="math inline">\(S(t)=\exp (-\Lambda(t)).\)</span> However, <span
class="math inline">\(\exp
\left(-\Lambda_{\mathrm{k}}(\mathrm{t})\right)\)</span> is in general
not interpretable as the survival function for cause <span
class="math inline">\(\mathrm{k}\)</span> alone unless additional
assumptions are made that cannot be verified in competing risks
data.</p>
<pre><code>*** competing events censored;
proc phreg data＝cohort zph；
    * class cov1(order=internal ref=&#39;3&#39;);
    model time*Status(0，2)＝cov1~covn /ties＝efron rl；
    assess ph/resample seed＝1234；
run；

*** Effect of competing events;
proc phreg data＝cohort zph； 
    model time*Status(0，1)＝cov1~covn /ties＝efron rl；
    assess ph/resample seed＝1234；
run；</code></pre>
</div>
<div id="cause_specific_sel" class="section level3">
<h3>%Cause_Specific_SEL</h3>
<p>To conduct multivariate backward selection Cause-Specific Hazard
model on competing risk survival data. For a particular cause of
interest, we treat all the competing events as censored observations in
the analysis. The risk set at each time includes only those subjects who
have not failed from competing events or are truly censored.</p>
</div>
</div>
</div>
<div id="competing-risk-analysis-in-r" class="section level1">
<h1>Competing Risk Analysis in R</h1>
<p>We will use the Melanoma data from the {MASS} package to illustrate
these concepts. It contains variables:</p>
<ul>
<li>time survival time in days, possibly censored.</li>
<li>status 1 died from melanoma, 2 alive, 3 dead from other causes.</li>
<li>sex 1 = male, 0 = female.</li>
<li>age age in years.</li>
<li>year of operation.</li>
<li>thickness tumor thickness in mm.</li>
<li>ulcer 1 = presence, 0 = absence.</li>
</ul>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":[""],"name":["_rn_"],"type":[""],"align":["left"]},{"label":["time"],"name":[1],"type":["int"],"align":["right"]},{"label":["status"],"name":[2],"type":["fct"],"align":["left"]},{"label":["sex"],"name":[3],"type":["int"],"align":["right"]},{"label":["age"],"name":[4],"type":["int"],"align":["right"]},{"label":["year"],"name":[5],"type":["int"],"align":["right"]},{"label":["thickness"],"name":[6],"type":["dbl"],"align":["right"]},{"label":["ulcer"],"name":[7],"type":["int"],"align":["right"]}],"data":[{"1":"10","2":"2","3":"1","4":"76","5":"1972","6":"6.76","7":"1","_rn_":"1"},{"1":"30","2":"2","3":"1","4":"56","5":"1968","6":"0.65","7":"0","_rn_":"2"},{"1":"35","2":"0","3":"1","4":"41","5":"1977","6":"1.34","7":"0","_rn_":"3"},{"1":"99","2":"2","3":"0","4":"71","5":"1968","6":"2.90","7":"0","_rn_":"4"},{"1":"185","2":"1","3":"1","4":"52","5":"1965","6":"12.08","7":"1","_rn_":"5"},{"1":"204","2":"1","3":"1","4":"28","5":"1971","6":"4.84","7":"1","_rn_":"6"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
<div id="cumulative-incidence" class="section level2">
<h2>Cumulative Incidence</h2>
<p>A non-parametric estimate of the cumulative incidence of the event of
interest. At any point in time, the sum of the cumulative incidence of
each event is equal to the total cumulative incidence of any event (not
true in the cause-specific setting). Gray’s test is a modified
Chi-squared test used to compare 2 or more groups.</p>
<p>Estimate the cumulative incidence in the context of competing risks
using the cuminc function from the {<strong>tidycmprsk</strong>}
package. By default this requires the status to be a factor variable
with censored patients coded as 0.</p>
<pre><code>## time    n.risk   estimate   std.error   95% CI          
## 1,000   171      0.127      0.023       0.086, 0.177    
## 2,000   103      0.230      0.030       0.174, 0.291    
## 3,000   54       0.310      0.037       0.239, 0.383    
## 4,000   13       0.339      0.041       0.260, 0.419    
## 5,000   1        0.339      0.041       0.260, 0.419</code></pre>
<pre><code>## time    n.risk   estimate   std.error   95% CI          
## 1,000   171      0.034      0.013       0.015, 0.066    
## 2,000   103      0.050      0.016       0.026, 0.087    
## 3,000   54       0.058      0.017       0.030, 0.099    
## 4,000   13       0.106      0.032       0.053, 0.179    
## 5,000   1        0.106      0.032       0.053, 0.179</code></pre>
<p>Now let’s say we wanted to examine death from melanoma or other
causes in the Melanoma data, according to ulcer, the presence or absence
of ulceration. We can estimate the cumulative incidence at various times
by group and display that in a table using the tbl_cuminc() function
from the {tidycmprsk} package, and add Gray’s test to test for a
difference between groups over the entire follow-up period using the
add_p() function.</p>
<div id="bnxnykledf" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>#bnxnykledf table {
  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

#bnxnykledf thead, #bnxnykledf tbody, #bnxnykledf tfoot, #bnxnykledf tr, #bnxnykledf td, #bnxnykledf th {
  border-style: none;
}

#bnxnykledf p {
  margin: 0;
  padding: 0;
}

#bnxnykledf .gt_table {
  display: table;
  border-collapse: collapse;
  line-height: normal;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#bnxnykledf .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#bnxnykledf .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#bnxnykledf .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 3px;
  padding-bottom: 5px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#bnxnykledf .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#bnxnykledf .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bnxnykledf .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#bnxnykledf .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#bnxnykledf .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#bnxnykledf .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#bnxnykledf .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#bnxnykledf .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#bnxnykledf .gt_spanner_row {
  border-bottom-style: hidden;
}

#bnxnykledf .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#bnxnykledf .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#bnxnykledf .gt_from_md > :first-child {
  margin-top: 0;
}

#bnxnykledf .gt_from_md > :last-child {
  margin-bottom: 0;
}

#bnxnykledf .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#bnxnykledf .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#bnxnykledf .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#bnxnykledf .gt_row_group_first td {
  border-top-width: 2px;
}

#bnxnykledf .gt_row_group_first th {
  border-top-width: 2px;
}

#bnxnykledf .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#bnxnykledf .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#bnxnykledf .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#bnxnykledf .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bnxnykledf .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#bnxnykledf .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#bnxnykledf .gt_last_grand_summary_row_top {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: double;
  border-bottom-width: 6px;
  border-bottom-color: #D3D3D3;
}

#bnxnykledf .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#bnxnykledf .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bnxnykledf .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#bnxnykledf .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#bnxnykledf .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#bnxnykledf .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#bnxnykledf .gt_left {
  text-align: left;
}

#bnxnykledf .gt_center {
  text-align: center;
}

#bnxnykledf .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#bnxnykledf .gt_font_normal {
  font-weight: normal;
}

#bnxnykledf .gt_font_bold {
  font-weight: bold;
}

#bnxnykledf .gt_font_italic {
  font-style: italic;
}

#bnxnykledf .gt_super {
  font-size: 65%;
}

#bnxnykledf .gt_footnote_marks {
  font-size: 75%;
  vertical-align: 0.4em;
  position: initial;
}

#bnxnykledf .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#bnxnykledf .gt_indent_1 {
  text-indent: 5px;
}

#bnxnykledf .gt_indent_2 {
  text-indent: 10px;
}

#bnxnykledf .gt_indent_3 {
  text-indent: 15px;
}

#bnxnykledf .gt_indent_4 {
  text-indent: 20px;
}

#bnxnykledf .gt_indent_5 {
  text-indent: 25px;
}

#bnxnykledf .katex-display {
  display: inline-flex !important;
  margin-bottom: 0.75em !important;
}

#bnxnykledf div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {
  height: 0px !important;
}
</style>
<table class="gt_table" data-quarto-disable-processing="false" data-quarto-bootstrap="false">
  <thead>
    <tr class="gt_col_headings">
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="label"><span class='gt_from_md'><strong>Characteristic</strong></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="stat_1"><span class='gt_from_md'><strong>5-year cuminc</strong></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="p.value"><span class='gt_from_md'><strong>p-value</strong></span><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span></th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td headers="label" class="gt_row gt_left">ulcer</td>
<td headers="stat_1" class="gt_row gt_center"><br /></td>
<td headers="p.value" class="gt_row gt_center"><0.001</td></tr>
    <tr><td headers="label" class="gt_row gt_left">0</td>
<td headers="stat_1" class="gt_row gt_center">9.1% (4.6%, 15%)</td>
<td headers="p.value" class="gt_row gt_center"><br /></td></tr>
    <tr><td headers="label" class="gt_row gt_left">1</td>
<td headers="stat_1" class="gt_row gt_center">39% (29%, 49%)</td>
<td headers="p.value" class="gt_row gt_center"><br /></td></tr>
  </tbody>
  
  <tfoot class="gt_footnotes">
    <tr>
      <td class="gt_footnote" colspan="3"><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span> <span class='gt_from_md'>Gray’s Test</span></td>
    </tr>
  </tfoot>
</table>
</div>
</div>
<div id="cif-plot" class="section level2">
<h2>CIF Plot</h2>
<p>We can use the ggcuminc() function from the {ggsurvfit} package to
plot the cumulative incidence. By default it plots the first event type
only. So the following plot shows the cumulative incidence of death from
melanoma:</p>
<p><img src="06-Analysis-Survival-Competing-Risk_files/figure-html/unnamed-chunk-4-1.png" width="672" /><img src="06-Analysis-Survival-Competing-Risk_files/figure-html/unnamed-chunk-4-2.png" width="672" /><img src="06-Analysis-Survival-Competing-Risk_files/figure-html/unnamed-chunk-4-3.png" width="672" /></p>
</div>
<div id="competing-risks-regression" class="section level2">
<h2>Competing risks regression</h2>
<p>There are two approaches to competing risks regression:</p>
<ol style="list-style-type: decimal">
<li>Cause-specific hazards
<ul>
<li>instantaneous rate of occurrence of the given type of event in
subjects who are currently event‐free</li>
<li>estimated using Cox regression (coxph function)</li>
</ul></li>
<li>Subdistribution hazards
<ul>
<li>instantaneous rate of occurrence of the given type of event in
subjects who have not yet experienced an event of that type</li>
<li>estimated using Fine-Gray regression (crr function)</li>
</ul></li>
</ol>
<div id="subdistribution-hazards" class="section level3">
<h3>Subdistribution hazards</h3>
<p>The crr() function from the {tidycmprsk} package will estimate the
subdistribution hazards.</p>
<pre><code>## 
## Variable   Coef    SE      HR     95% CI       p-value    
## sex        0.588   0.272   1.80   1.06, 3.07   0.030      
## age        0.013   0.009   1.01   0.99, 1.03   0.18</code></pre>
<div id="bzbjonpfmy" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>#bzbjonpfmy table {
  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

#bzbjonpfmy thead, #bzbjonpfmy tbody, #bzbjonpfmy tfoot, #bzbjonpfmy tr, #bzbjonpfmy td, #bzbjonpfmy th {
  border-style: none;
}

#bzbjonpfmy p {
  margin: 0;
  padding: 0;
}

#bzbjonpfmy .gt_table {
  display: table;
  border-collapse: collapse;
  line-height: normal;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#bzbjonpfmy .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#bzbjonpfmy .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#bzbjonpfmy .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 3px;
  padding-bottom: 5px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#bzbjonpfmy .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#bzbjonpfmy .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bzbjonpfmy .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#bzbjonpfmy .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#bzbjonpfmy .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#bzbjonpfmy .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#bzbjonpfmy .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#bzbjonpfmy .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#bzbjonpfmy .gt_spanner_row {
  border-bottom-style: hidden;
}

#bzbjonpfmy .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#bzbjonpfmy .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#bzbjonpfmy .gt_from_md > :first-child {
  margin-top: 0;
}

#bzbjonpfmy .gt_from_md > :last-child {
  margin-bottom: 0;
}

#bzbjonpfmy .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#bzbjonpfmy .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#bzbjonpfmy .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#bzbjonpfmy .gt_row_group_first td {
  border-top-width: 2px;
}

#bzbjonpfmy .gt_row_group_first th {
  border-top-width: 2px;
}

#bzbjonpfmy .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#bzbjonpfmy .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#bzbjonpfmy .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#bzbjonpfmy .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bzbjonpfmy .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#bzbjonpfmy .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#bzbjonpfmy .gt_last_grand_summary_row_top {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: double;
  border-bottom-width: 6px;
  border-bottom-color: #D3D3D3;
}

#bzbjonpfmy .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#bzbjonpfmy .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#bzbjonpfmy .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#bzbjonpfmy .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#bzbjonpfmy .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#bzbjonpfmy .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#bzbjonpfmy .gt_left {
  text-align: left;
}

#bzbjonpfmy .gt_center {
  text-align: center;
}

#bzbjonpfmy .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#bzbjonpfmy .gt_font_normal {
  font-weight: normal;
}

#bzbjonpfmy .gt_font_bold {
  font-weight: bold;
}

#bzbjonpfmy .gt_font_italic {
  font-style: italic;
}

#bzbjonpfmy .gt_super {
  font-size: 65%;
}

#bzbjonpfmy .gt_footnote_marks {
  font-size: 75%;
  vertical-align: 0.4em;
  position: initial;
}

#bzbjonpfmy .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#bzbjonpfmy .gt_indent_1 {
  text-indent: 5px;
}

#bzbjonpfmy .gt_indent_2 {
  text-indent: 10px;
}

#bzbjonpfmy .gt_indent_3 {
  text-indent: 15px;
}

#bzbjonpfmy .gt_indent_4 {
  text-indent: 20px;
}

#bzbjonpfmy .gt_indent_5 {
  text-indent: 25px;
}

#bzbjonpfmy .katex-display {
  display: inline-flex !important;
  margin-bottom: 0.75em !important;
}

#bzbjonpfmy div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {
  height: 0px !important;
}
</style>
<table class="gt_table" data-quarto-disable-processing="false" data-quarto-bootstrap="false">
  <thead>
    <tr class="gt_col_headings">
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="label"><span class='gt_from_md'><strong>Characteristic</strong></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="estimate"><span class='gt_from_md'><strong>HR</strong></span><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="conf.low"><span class='gt_from_md'><strong>95% CI</strong></span><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="p.value"><span class='gt_from_md'><strong>p-value</strong></span></th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td headers="label" class="gt_row gt_left">sex</td>
<td headers="estimate" class="gt_row gt_center">1.80</td>
<td headers="conf.low" class="gt_row gt_center">1.06, 3.07</td>
<td headers="p.value" class="gt_row gt_center">0.030</td></tr>
    <tr><td headers="label" class="gt_row gt_left">age</td>
<td headers="estimate" class="gt_row gt_center">1.01</td>
<td headers="conf.low" class="gt_row gt_center">0.99, 1.03</td>
<td headers="p.value" class="gt_row gt_center">0.2</td></tr>
  </tbody>
  
  <tfoot class="gt_footnotes">
    <tr>
      <td class="gt_footnote" colspan="4"><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span> <span class='gt_from_md'>HR = Hazard Ratio, CI = Confidence Interval</span></td>
    </tr>
  </tfoot>
</table>
</div>
</div>
<div id="cause-specific-hazards" class="section level3">
<h3>Cause-specific hazards</h3>
<p>Alternatively, if we wanted to use the cause-specific hazards
regression approach, we first need to censor all subjects who didn’t
have the event of interest, in this case death from melanoma, and then
use coxph as before. So patients who died from other causes are now
censored for the cause-specific hazard approach to competing risks.
Again we generate a table of formatted results using the
tbl_regression() function from the {gtsummary} package:</p>
<div id="wgipiasbbp" style="padding-left:0px;padding-right:0px;padding-top:10px;padding-bottom:10px;overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>#wgipiasbbp table {
  font-family: system-ui, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Noto Color Emoji';
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}

#wgipiasbbp thead, #wgipiasbbp tbody, #wgipiasbbp tfoot, #wgipiasbbp tr, #wgipiasbbp td, #wgipiasbbp th {
  border-style: none;
}

#wgipiasbbp p {
  margin: 0;
  padding: 0;
}

#wgipiasbbp .gt_table {
  display: table;
  border-collapse: collapse;
  line-height: normal;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#wgipiasbbp .gt_caption {
  padding-top: 4px;
  padding-bottom: 4px;
}

#wgipiasbbp .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#wgipiasbbp .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 3px;
  padding-bottom: 5px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#wgipiasbbp .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#wgipiasbbp .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#wgipiasbbp .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#wgipiasbbp .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#wgipiasbbp .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#wgipiasbbp .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#wgipiasbbp .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#wgipiasbbp .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#wgipiasbbp .gt_spanner_row {
  border-bottom-style: hidden;
}

#wgipiasbbp .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  text-align: left;
}

#wgipiasbbp .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#wgipiasbbp .gt_from_md > :first-child {
  margin-top: 0;
}

#wgipiasbbp .gt_from_md > :last-child {
  margin-bottom: 0;
}

#wgipiasbbp .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#wgipiasbbp .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#wgipiasbbp .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#wgipiasbbp .gt_row_group_first td {
  border-top-width: 2px;
}

#wgipiasbbp .gt_row_group_first th {
  border-top-width: 2px;
}

#wgipiasbbp .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#wgipiasbbp .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#wgipiasbbp .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#wgipiasbbp .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#wgipiasbbp .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#wgipiasbbp .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#wgipiasbbp .gt_last_grand_summary_row_top {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: double;
  border-bottom-width: 6px;
  border-bottom-color: #D3D3D3;
}

#wgipiasbbp .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#wgipiasbbp .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#wgipiasbbp .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#wgipiasbbp .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#wgipiasbbp .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#wgipiasbbp .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#wgipiasbbp .gt_left {
  text-align: left;
}

#wgipiasbbp .gt_center {
  text-align: center;
}

#wgipiasbbp .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#wgipiasbbp .gt_font_normal {
  font-weight: normal;
}

#wgipiasbbp .gt_font_bold {
  font-weight: bold;
}

#wgipiasbbp .gt_font_italic {
  font-style: italic;
}

#wgipiasbbp .gt_super {
  font-size: 65%;
}

#wgipiasbbp .gt_footnote_marks {
  font-size: 75%;
  vertical-align: 0.4em;
  position: initial;
}

#wgipiasbbp .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#wgipiasbbp .gt_indent_1 {
  text-indent: 5px;
}

#wgipiasbbp .gt_indent_2 {
  text-indent: 10px;
}

#wgipiasbbp .gt_indent_3 {
  text-indent: 15px;
}

#wgipiasbbp .gt_indent_4 {
  text-indent: 20px;
}

#wgipiasbbp .gt_indent_5 {
  text-indent: 25px;
}

#wgipiasbbp .katex-display {
  display: inline-flex !important;
  margin-bottom: 0.75em !important;
}

#wgipiasbbp div.Reactable > div.rt-table > div.rt-thead > div.rt-tr.rt-tr-group-header > div.rt-th-group:after {
  height: 0px !important;
}
</style>
<table class="gt_table" data-quarto-disable-processing="false" data-quarto-bootstrap="false">
  <thead>
    <tr class="gt_col_headings">
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1" scope="col" id="label"><span class='gt_from_md'><strong>Characteristic</strong></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="estimate"><span class='gt_from_md'><strong>HR</strong></span><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="conf.low"><span class='gt_from_md'><strong>95% CI</strong></span><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span></th>
      <th class="gt_col_heading gt_columns_bottom_border gt_center" rowspan="1" colspan="1" scope="col" id="p.value"><span class='gt_from_md'><strong>p-value</strong></span></th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td headers="label" class="gt_row gt_left">sex</td>
<td headers="estimate" class="gt_row gt_center">1.82</td>
<td headers="conf.low" class="gt_row gt_center">1.08, 3.07</td>
<td headers="p.value" class="gt_row gt_center">0.025</td></tr>
    <tr><td headers="label" class="gt_row gt_left">age</td>
<td headers="estimate" class="gt_row gt_center">1.02</td>
<td headers="conf.low" class="gt_row gt_center">1.00, 1.03</td>
<td headers="p.value" class="gt_row gt_center">0.056</td></tr>
  </tbody>
  
  <tfoot class="gt_footnotes">
    <tr>
      <td class="gt_footnote" colspan="4"><span class="gt_footnote_marks" style="white-space:nowrap;font-style:italic;font-weight:normal;line-height:0;"><sup>1</sup></span> <span class='gt_from_md'>HR = Hazard Ratio, CI = Confidence Interval</span></td>
    </tr>
  </tfoot>
</table>
</div>
</div>
</div>
</div>
<div id="reference" class="section level1">
<h1>Reference</h1>
<ul>
<li><a
href="https://www.emilyzabor.com/tutorials/survival_analysis_in_r_tutorial.html#Part_3:_Competing_Risks">Survival
Analysis in R</a></li>
<li>Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of
competing risks regression models. Clin Cancer Res.
2012;18(8):2301-8.</li>
<li>Kim HT. Cumulative incidence in competing risks data and competing
risks regression analysis. Clin Cancer Res. 2007 Jan 15;13(2 Pt
1):559-65.</li>
<li>Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach
AD. A note on competing risks in survival data analysis. Br J Cancer.
2004;91(7):1229-35.</li>
<li>Austin, P., &amp; Fine, J. (2017). Practical recommendations for
reporting Fine‐Gray model analyses for competing risk data. Statistics
in Medicine, 36(27), 4391-4400.</li>
</ul>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
